CC
SGFY

Carlson Capital’s Signify Health, Inc. SGFY Stock Holding History

Carlson Capital’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-700,000
Closed -$20.4M – 151
2022
Q3 		$20.4M Buy
+700,000
New +$16.1M 1.54% 19

Other funds holding SGFY

NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Carlson Capital's SGFY Position: Q4 2022 in Review

Carlson Capital sold out of Signify Health, Inc. (SGFY) in Q4 2022, closing a stake of 700,000 shares — an estimated $20.4M sold.

Carlson Capital first reported a position in SGFY in Q3 2022 and held it in 1 quarter. The position peaked at $20.4M in Q3 2022. 205 funds tracked by Wall St. Rank hold SGFY as of Q4 2022.

  • Carlson Capital reported no remaining Signify Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Carlson Capital sold 700,000 Signify Health, Inc. shares in Q4 2022, an estimated $20.4M.
  • Carlson Capital first reported a position in Signify Health, Inc. in Q3 2022 and held it in 1 quarter.
  • Carlson Capital's Signify Health, Inc. position peaked at $20.4M in Q3 2022.
  • 205 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q4 2022.

Based on Carlson Capital's 13F filing for Q4 2022, filed 14 Feb 2023.